Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex… Source: BioSpace You Might Also Like SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity February 16, 2017 <b>StoneCalibre</b> Affiliate Acquires In-Vitro Diagnostics Products Provider <b>Alpha-Tec Systems</b> July 18, 2017 Celgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials December 28, 2017
SAGE Therapeutics Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity February 16, 2017
<b>StoneCalibre</b> Affiliate Acquires In-Vitro Diagnostics Products Provider <b>Alpha-Tec Systems</b> July 18, 2017
